Selective toxicity of ginsenoside Rg3 on multidrug resistant cells by membrane fluidity modulation

Archives of Pharmacal Research

Volumn 31, Issue 2, 2008, Pages 171-177

  Kwon, Hyog Young ^a   Kim, Eun Hye ^a   Kim, Seung Whan ^b   Kim, Su Nam ^c   Park, Jong Dae ^d   Rhee, Dong Kwon ^a  

^a Sungkyunkwan University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

^d KT and G Corporation   (South Korea)

Author keywords

20(S) ginsenoside Rg3; Ginsenosides; Multidrug resistance (MDR); Panax ginseng

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN; FLUORESCENT DYE; GINSENOSIDE; GINSENOSIDE RG 3; RHODAMINE 123;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CELL STRAIN KB; DRUG EFFECT; DRUG RESISTANCE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE POLARIZATION; HUMAN; LEUKEMIA P 388; MEMBRANE FLUIDITY; MOUSE; MULTIDRUG RESISTANCE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; FLUORESCENCE POLARIZATION; FLUORESCENT DYES; GINSENOSIDES; HUMANS; KB CELLS; LEUKEMIA P388; MEMBRANE FLUIDITY; MICE; NEOPLASM TRANSPLANTATION; RHODAMINE 123;

EID: 42949124575     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-001-1137-y     Document Type: Article

References (39)

1. Atadja, P., Watanabe, T., Xu, H., and Cohen, D., PSC-833, a frontier in modulation of P-glycoprotein mediated multidrug resistance. Cancer Metastasis Rev., 17, 163-168 (1998).
2. Attele, A. S., Wu, J. A., and Yuan, C. S., Ginseng pharmacology: multiple constituents and multiple actions. Biochem. Pharmacol., 58, 1685-1693 (1999).
3. Benson, A. B. 3rd, Trump, D. L., Koeller, J. M., Egorin, M. I., Olman, E. A., Witte, R. S., Davis, T. E., and Tormey, D. C., Phase I study of vinblastine and verapamil given by concurrent iv infusion. Cancer Treat. Rep., 69, 795-799 (1985).
4. Ben-Yashar, V. and Barenholz, Y., Characterization of the core and surface of human plasma lipoproteins. A study based on the use of five fluorophores. Chem. Phys. Lipids, 60, 1-14 (1991).
5. Bichat, F., Solis-Recendez, G., Poullain, M. G., Poupon, M. F., Khayat, D., and Bastian G., S9788 modulation of P-glycoprotein-and multidrug-related protein-mediated multidrug resistance by Servier 9788 in doxorubicin-resistant MCF7 cells. Biochem. Pharmacol., 56, 497-502 (1998).
6. Chen, H.-X., Bamberger, U., Hechel, A., Guo, X., and Cheng, Y. C., BIBW22, a dipyridamole analog, acts as a bifunctional modulator on tumor cells by influencing both p-glycogen and and nucleoside transport. Cancer Res., 53, 1974-1977 (1993).
7. Dale, I. L., Tuffley, W., Callaghan, R., Holmes, J. A., Martin, K., Luscombe, M., Mistry, P., Ryder, H., Stewart, A. J., Charlton, P., Twentyman, P. R., and Bevan, P., Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative. Br. J. Cancer, 78, 885-892 (1998).
8. Endicott, J. A. and Ling, V., The biochemistry of p-glycoprotein-mediated multidrug resistance. Ann. Rev. Biochem., 58, 137-171 (1989).
9. Ford, J. M. and Hait, W. N., Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev., 42, 155-199 (1990).
10. Germann, U. A., Ford, P. J., Shlyakhter, D., Mason, V. S., and Harding, M. W., Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP. Anticancer Drugs, 8, 141-155 (1997).
11. Gillis, C.N., Panax ginseng pharmacology: a nitric oxide link? Biochem. Pharmacol., 54, 1-8 (1997).
12. Gottesman, M. M. and Pastan, I., Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann. Rev. Biochem., 62, 385-427 (1993).
13. Gros, P., Ben Neriah, Y., Croop, J. M., and Housman, D. E., Isolation and expression of a complementary DNA that confers multidrug resistance. Nature, 323, 728-731 (1986).
14. Herzog, C. E., Tsokos, M., Bates, S. E., and Fojo, A.T., Increased mdr1/p-glycoprotein expression after treatment of human colon carcinoma cells with p-glycoprotein antagonists. J. Biol. Chem., 268, 2946-2952 (1993).
15. Jancis, E. M., Chen, H. X., Carbone, R., Hochberg, R. B., and Dannies, P. S., Rapid stimulation of rhodamine 123 efflux from multidrug-resistant KB cells by progesterone. Biochem. Pharmacol., 46, 1613-1619 (1993).
16. Jin, Y. H., Yoo, K. J., Lee, Y. H., and Lee, S. K., Caspase 3-mediated cleavage of p21WAF1/CIP1 associated with the cyclin A-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells. J. Biol. Chem., 275, 30256-30263 (2000).
17. Kim, S. I., Park, J. D., Lee, Y. H., Nam, G. Y., and Baek, N. I., Preparation of 20 (R)-and 20 (S)-ginsenoside Rh1 from ginsenoside Re. Korean J. Ginseng Sci., 15, 188-191 (1991).
18. Kim, S. W., Kwon, H. Y., Chi, D. W., Shim, J. H., Park, J. D., Lee, Y. H., Pyo, S., and Rhee, D. K., Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg(3). Biochem. Pharmacol., 65, 75-82 (2003).
19. Kitagawa, I., Yoshikawa, M., Yoshihara, M., Hayashi, T., and Taniyama, T., Chemical studies of crude drugs (1). Constituents of Ginseng radix rubra. Yakugaku Zasshi, 103, 612-622 (1983).
20. Lewis, K., In search of natural substrates and inhibitors of MDR pumps. J. Mol. Microbiol. Biotechnol., 3, 247-254 (2001).
21. Ludescher, C., Gattringer, Drach, J., Hofmann, J., and Grunicke, H., Rapid functional assay for the detection of multidrug-resistant cells using the fluorescent dye rhodamine 123. Blood, 78, 1385-1387 (1991).
22. Markus, R. and Werner, S., Clinical trials of agents that reverse multidrug resistance. Cancer, 72, 3533-3563 (1993).
23. McDevitt, C. A. and Callaghan, R., How can we best use structural information on P-glycoprotein to design inhibitors? Pharmacol. Ther., 113, 429-441 (2007).
24. Merino-Montero, S., Montero, M. T., and Hernandez-Borrell, J., Effects of lactose permease of Escherichia coli on the anisotropy and electrostatic surface potential of liposomes. Biophys. Chem., 119, 101-105 (2006).
25. Mirski, S. E. I., Gerlach, J. H., and Cole, S. P. C., Multidrug resistance in a human small cell lung cancer cell line selected in Adriamycin. Cancer Res., 47, 2594-2598 (1987).
26. Molnar, J., Szabo, D., Pusztai, R., Mucsi, I., Berek, L., Ocsovszki, I., Kawata, E., and Shoyama, Y., Membrane associated antitumor effects of crocine-, ginsenoside-and cannabinoid derivates. Anticancer Res., 20, 861-867 (2000).
27. Newman, M. J., Rodarte, J. C., Benbatoul, K. D., Romano, S. J., Zhang, C., Krane, S., Moran, E. J., Uyeda, R. T., Dixon, R., Guns, E. S., and Mayer, L. D., Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance. Cancer Res., 60, 2964-2972 (2000).
28. Park, J. D., Kim, D. S., Kwon, H. Y., Son, S. K., Lee, Y. H., Baek, N. I., Kim, S. I., and Rhee, D. K., Effects of ginseng saponin on modulation of multidrug resistance. Arch. Pharm. Res., 19, 213-218 (1996).
29. Pastan, I., Gottesman, M. M., Ueda, K., Lovelace, E., Rutherford, A. V., and Willingham, M. C., Retrovirus carrying an mdr1 cDNA confers multidrug resistance and polarized expression of p-glycoprotein in MDCK cells. Proc. Natl. Acad. Sci. USA., 85, 4486-4490 (1988).
30. Perez-Tomas, R., Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. Curr. Med. Chem., 13, 1859-1876 (2006).
31. Sinicrope, F. A., Dudeja, P. K., Bissonnette, B. M., Safa, A. R., and Brasitus, T. A., Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles. J. Biol. Chem., 267, 24995-5002 (1992).
32. Sparreboom, A., Planting, A. S., Jewell, R. C., van der Burg, M. E., van der Gaast, A., de Bruijn, P., Loos, W. J., Nooter, K., Chandler, L. H., Paul, E. M., Wissel, P. S., and Verweij, J., Clinical pharmacokinetics of doxorubicin in combination with GF120918, a potent inhibitor of MDR1 P-glycoprotein. Anticancer Drugs, 10, 719-728 (1999).
33. Sutter, M., Fiechter, T., and Imanidis, G., Correlation of membrane order and dynamics derived from time-resolved fluorescence measurements with solute permeability. J. Pharm. Sci., 93, 2090-2107 (2004).
34. Tsuruo, T., Iida, H., Tsukagoshi, S., and Sakurai, Y., Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res., 41, 1967-1972 (1981).
35. Vanhoefer, U., Cao, S., Minderman, H., Toth, K., Scheper, R. J., Slovak, M. L., and Rustum, Y. M., PAK-104P, a pyridine analogue, reverses paclitaxel and doxorubicin resistance in cell lines and nude mice bearing xenografts that overexpress the multidrug resistance protein. Clin. Cancer Res., 2, 369-377 (1996).
36. Whiting, K. P., Restall, C. J., and Brain, P. F., Steroid hormone-induced effects on membrane fluidity and their potential roles in non-genomic mechanisms. Life Sci., 67, 743-757 (2000).
37. Woodcock, D. M., Linsenmeyer, M. E., Chojnowski, G., Kriegler, A. B., Nink, V., Webster, L. K., and Sawyer, W. H., Reversal of multidrug resistance by surfactants. Br. J. Cancer, 66, 62-88 (1992).
38. Yang, C. P., DePinho, S. G., Greenberger, L. M., Arceci, R. J., and Horwitz, S. B., Progesterone interacts with P-glycoprotein in multidrug-resistant cells and the endometrium of gravid uterus. J. Biol. Chem., 265, 782-788 (1989).
39. Yoshimura, A., Shudo, N., Ikeda, S. I., Ichikawa, M., Sumizawa, T., and Akiyama, S., Novel screening method for agents that overcome classical multidrug resistance in a human cell line. Cancer Lett., 50, 45-51 (1990).